Production process of heparin sodium in porcine small intestine mucosa
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 胡晓辉
- Publication Date
- 2019-03-26
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention relates to a production process of heparin sodium, in particular to a production process of heparin sodium for pig small intestinal mucosa. Background technique
[0002] Heparin is a mucopolysaccharide that widely exists in mammalian tissues, mainly exists in mast cells, has anticoagulant effect, and is widely used in the treatment of surgery, cerebral thrombosis, myocardial infarction, etc. The molecular weight of heparin is about 3000-37500, and research on commercial heparin suggests that there are at least 21 molecular entities. Heparin sodium is the sodium salt of heparin. As a natural anticoagulant substance, heparin sodium has been valued by countries all over the world. It is also one of the main export drugs in my country. With the deepening of research, it has been found that heparin sodium not only has anticoagulant, antithrombotic and blood lipid regulation effects, but also has anti Inflammation, anti-allergy, anti-virus, an...